Waterloo, ON – July 20, 2026 – illumiSonics is pleased to announce the launch of a new clinical trial in collaboration with Sunnybrook Research Institute, supported by funding from the INOVAIT Focus Fund. This prospective study will evaluate illumiSonics' proprietary Multi-Laser Imaging (MLI™) platform during Mohs micrographic surgery for skin cancer. The trial will compare MLI™ virtual histology with conventional frozen-section pathology to assess the technology's ability to

In collaboration with the research team led by Prof. Kathleen Hill [Biology, Western University], we are exploring how Multi-Laser Imaging (MLI™) can reveal rich biological information from unstained tissue.

Intraoperative histology is a cornerstone of surgical oncology, yet clinicians face a trade-off between speed and structural detail. Frozen sections can be rapid but give poor and variable histology, while standard histology gives rich architectural and histology information but only after the surgery is completed. This raw whole-slide MLI™ of healthy murine brain tissue shows a label-free approach that captures detailed structural information without staining, or other chemi

May 19, 2026 — illumiSonics has been featured in BioTuesdays in an article highlighting the company’s proprietary multi-laser imaging technology, MLI™, and its potential to transform tissue imaging across pathology, surgical imaging, and ophthalmology. The article profiles illumiSonics’ mission to generate multiple diagnostic outputs from a single, label-free scan, helping simplify workflows, preserving scarce tissue, and unlocking new biological insights. “Our broader ambiti

March 18, 2026 - illumiSonics Inc., a leading innovator in advanced biomedical imaging technologies, is pleased to announce the appointment of James Tweel as Principal Research Scientist. Dr. Tweel brings extensive expertise in biomedical imaging and has played a critical role in the development of the company’s core technologies, PARS® (Photon Absorption Remote Sensing) and MLI™ (Multi-Laser Imaging), which serve as central pillars of illumiSonics’ proprietary imaging platfo